Cargando…
Poly- and autoreactivity of HIV-1 bNAbs: implications for vaccine design
A central puzzle in HIV-1 research is the inability of vaccination or even infection to reliably elicit humoral responses against broadly neutralizing epitopes in the HIV-1 envelope protein. In infected individuals, broadly neutralizing antibodies (bNAbs) do arise in a substantial minority, but only...
Autores principales: | Finney, Joel, Kelsoe, Garnett |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6064052/ https://www.ncbi.nlm.nih.gov/pubmed/30055635 http://dx.doi.org/10.1186/s12977-018-0435-0 |
Ejemplares similares
-
Probabilities of developing HIV-1 bNAb sequence features in uninfected and chronically infected individuals
por: Kreer, Christoph, et al.
Publicado: (2023) -
A site of vulnerability at V3 crown defined by HIV-1 bNAb M4008_N1
por: Chan, Kun-Wei, et al.
Publicado: (2021) -
Recombinant HIV Envelope Proteins Fail to Engage Germline Versions of Anti-CD4bs bNAbs
por: Hoot, Sam, et al.
Publicado: (2013) -
Correction: Recombinant HIV Envelope Proteins Fail to Engage Germline Versions of Anti-CD4bs bNAbs
por: Hoot, Sam, et al.
Publicado: (2013) -
To bnAb or Not to bnAb: Defining Broadly Neutralising Antibodies Against HIV-1
por: Griffith, Sarah A., et al.
Publicado: (2021)